Approach to Cerebrospinal Fluid (CSF) Biomarker Discovery and Evaluation in HIV Infection

Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection

(2013) Tricia H. Burdo et al.   AIDS

Risk for Opportunistic Disease and Death after Reinitiating Continuous Antiretroviral Therapy in Patients with HIV Previously Receiving Episodic Therapy

(2013)   ANNALS OF INTERNAL MEDICINE

Cerebrospinal Fluid and Neuroimaging Biomarker Abnormalities Suggest Early Neurological Injury in a Subset of Individuals During Primary HIV Infection

(2013) M. J. Peluso et al.   JOURNAL OF INFECTIOUS DISEASES

Cerebrospinal fluid neopterin decay characteristics after initiation of antiretroviral therapy

(2013) Aylin Yilmaz et al.   Journal of Neuroinflammation

HIV-1 Pathogenesis: The Virus

(2013) R. Swanstrom et al.   Cold Spring Harbor Perspectives in Medicine

Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load

(2012) Michael J. Peluso et al.   AIDS

Cognitive disorders in HIV-infected patients

(2012) Fabrice Bonnet et al.   AIDS

Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection

(2012) Anupa Kamat et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection

(2012) Victor Valcour et al.   JOURNAL OF INFECTIOUS DISEASES

Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

(2012) Jan Jessen Krut et al.   JOURNAL OF NEUROLOGY

HIV and Inflammation: Mechanisms and Consequences

(2012) Peter W. Hunt   Current HIV/AIDS Reports

The HIV-1 Env Protein: A Coat of Many Colors

(2012) Kathryn Twigg Arrildt et al.   Current HIV/AIDS Reports

Incidence of Post-Dural Puncture Headache in Research Volunteers

(2011) Sérgio Monteiro de Almeida et al.   HEADACHE

Antiretroviral drug treatment of CNS HIV-1 infection

(2011) A. Yilmaz et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Central Nervous System Immune Activation Characterizes Primary Human Immunodeficiency Virus 1 Infection Even in Participants With Minimal Cerebrospinal Fluid Viral Burden

(2011) Serena Spudich et al.   JOURNAL OF INFECTIOUS DISEASES

Raltegravir Treatment Intensification Does Not Alter Cerebrospinal Fluid HIV-1 Infection or Immunoactivation in Subjects on Suppressive Therapy

(2011) Viktor Dahl et al.   JOURNAL OF INFECTIOUS DISEASES

Amyloid-related biomarkers and axonal damage proteins in parkinsonian syndromes

(2011) Sara Bech et al.   PARKINSONISM & RELATED DISORDERS

HIV-1 Replication in the Central Nervous System Occurs in Two Distinct Cell Types

(2011) Gretja Schnell et al.   PLoS Pathogens

Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort

(2010) Marlene Smurzynski et al.   AIDS

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Incidence and Impact on Mortality of Severe Neurocognitive Disorders in Persons With and Without HIV Infection: A Danish Nationwide Cohort Study

(2010) F.-X. Lescure et al.   CLINICAL INFECTIOUS DISEASES

Discordance Between Cerebral Spinal Fluid and Plasma HIV Replication in Patients with Neurological Symptoms Who Are Receiving Suppressive Antiretroviral Therapy

(2010) Ana Canestri et al.   CLINICAL INFECTIOUS DISEASES

HIV‐1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

(2010) Arvid Edén et al.   JOURNAL OF INFECTIOUS DISEASES

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

(2010) R. K. Heaton et al.   NEUROLOGY

Soluble biomarkers and morbidity and mortality among people infected with HIV: summary of published reports from 1997 to 2010

(2010) James D Neaton et al.   Current Opinion in HIV and AIDS

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

(2010) Lars Hagberg et al.   AIDS Research and Therapy

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

(2009) Magnus Gisslén et al.   BMC Neurology

Persistent Intrathecal Immune Activation in HIV-1-Infected Individuals on Antiretroviral Therapy

(2009) Aylin Yilmaz et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Measurement of soluble inflammatory mediators in cerebrospinal fluid of human immunodeficiency virus–positive patients at distinct stages of infection by solid-phase protein array

(2009) Thorsten Nolting et al.   JOURNAL OF NEUROVIROLOGY

Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection

(2009) G. Schnell et al.   JOURNAL OF VIROLOGY

CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease

(2009) D. B. Clifford et al.   NEUROLOGY

The role of HIV in serious diseases other than AIDS

(2008) Andrew N Phillips et al.   AIDS

Differential effect of type I and type II interferons on neopterin production and amino acid metabolism in human astrocyte-derived cells

(2008) Oscar D. Cano et al.   NEUROSCIENCE LETTERS

Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy

(2007) Krishnan Bhaskaran et al.   ANNALS OF NEUROLOGY